Impact of the COVID-19 Pandemic on STIs and HIV Services in Sleman District, Yogyakarta, Indonesia
DOI:
https://doi.org/10.66344/jpad.v32i3.1964Abstract
Background Sexually transmitted infections (STIs) are currently the highest risk factor for transmitting HIV infection. The incidence of HIV and STIs increase every year and there are still many obstacles for People Living with HIV/AIDS (PLWHA) to get access to care and treatment. Since the WHO declared the COVID-19 pandemic and the implementation of regional quarantine and social distancing, the mobilization of people who should receive health services, including people with HIV and STIs, has decreased. These circumstances can neither achieve the Getting to Zeros program nor the triple elimination program. Currently, there are no reports on the impact of the COVID-19 pandemic on services and coverage of STIs and HIV in Indonesia. This study aimed to determine the impact, especially in Sleman Regency, Yogyakarta.
Methods This epidemiological survey was conducted with a retrospective design and used secondary data. Restrictions on community mobility were implemented to prevent the spread of COVID-19 starting in April 2020. Data were collected from three hospitals and three primary health care (PHCs) in Sleman Regency, Yogyakarta, Indonesia, with STIs and HIV services, namely Dr. Sardjito Hospital, UGM Academic Hospital, Yogyakarta, Sleman Regional General Hospital, Tempel 1 Primary Health Care, Depok 3 Primary Health Care and Mlati 1 Primary Health Care. Data came from the registry at the research sites. The data obtained were tabulated and presented in the form of a table and analyzed descriptively.
Results There was a decrease in patient visits to STIs and HIV services before and during the COVID-19 pandemic, by 34.48% and 0.23%, respectively. For laboratory examinations related to the diagnosis of STIs, there were variations in changes, whereby gonorrhea examinations decreased by 49.77%, examinations for detecting genital warts increased by 42.86%, VDRL examinations decreased by 40.22%, TPHA examinations decreased by 22.54% and HIV tests decreased by 4.12% in the period during the COVID-19 pandemic. For the number of visits by patients taking ARVs, there was an increase of 11.6% during the COVID-19 pandemic compared to before the COVID-19 pandemic. In laboratory examinations related to the triple elimination program in pregnant women, there were changes, namely in hepatitis B examination, there was an increase of 4.72%, HIV examination, a decrease of 1.54% and syphilis examination, there was a decrease of 1.15%.
Conclusion The COVID-19 pandemic has impacted some services related to STIs and HIV. Further research on a broader scale is needed to confirm the extent of the impact. Strategies to improve the examination and management of STIs and HIV cases must always be prepared and their effectiveness evaluated in their implementation during this pandemic or in the event of other disease outbreaks in the future.
References
1. Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Penanganan Infeksi Menular Seksual. 2016. Jakarta: Kementerian Kesehatan Republik Indonesia.
2. Direktorat Jenderal Pencegahan dan Pengendalian Penyakit. Laporan Perkembangan HIV AIDS & Penyakit Menular Seksual (PIMS) Triwulan I. 2021. Jakarta: Kementerian Kesehatan Republik Indonesia.
3. Direktorat Jenderal Pencegahan dan Pengendalian Penyakit. Program Pengendalian HIV AIDS dan PIMS Fasilitas Kesehatan Tingkat Pertama. 2017. Jakarta: Kementerian Kesehatan Republik Indonesia.
4. World Health Organization. Listings of WHO’s response to COVID-19. 2020.
Available from: https://www.who.int/news/item/29-06-2020-covidtimeline
5. Keputusan Presiden (KEPPRES) tentang Penetapan Bencana Nonalam Penyebaran Corona Virus Disease 2019 (COVID-19) Sebagai Bencana Nasional. 2020. Jakarta: Presiden Republik Indonesia.
6. Jiang H, Zhou Y, Tang W. Maintaining HIV care during the COVID-19 pandemic. Lancet HIV. 2020;7(5):e308-e309.
doi:10.1016/S2352-3018(20)30105-3
7. Menteri Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Republik Indonesia nomor 52 tahun 2017 tentang Eliminasi Penularan Human Immunodeficiency Virus, Sifilis, dan Hepatitis B dari Ibu ke anak. 2017. Jakarta: Sekretariat Negara.
8. Napoleon SC, Maynard MA, Almonte A, et al. Considerations for STI Clinics During the COVID-19 Pandemic. Sex Transm Dis. 2020;47(7):431-3. doi:10.1097/OLQ.0000000000001192
9. STDs Continue to Rise in the U.S. Press Release. 2019. Available from: Centers for Disease Control and Prevention. https://www.cdc.gov/nchhstp/newsroom/2019/2018-STD-surveillance-report-press-release.html
10. Centers for Disease Control and Prevention. CDC Fact Sheet: Incidence, Prevalence and Cost of Sexually Transmitted Infections in the United States. 2013. Available from: https://www.cdc.gov/std/stats/sti-estimates-fact-sheet-feb-2013.pdf.
11. El-Sadr WM, Justman J. Africa in the Path of Covid-19. N Engl J Med. 2020;383:e11.
12. Drain PK, Garrett N. SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV. EClinicalMedicine. 2020;22:100342. Published 2020 Apr 22. doi:10.1016/j.eclinm.2020.100342
13. Cusini M, Benardon S, Vidoni G, Brignolo L, Veraldi S, Mandolini PL. Trend of main STIs during COVID-19 pandemic in Milan, Italy. Sex Transm Infect. 2021;97(2):99. doi:10.1136/sextrans-2020-054608
14. Apalla Z, Lallas A, Mastraftsi S, et al. Impact of COVID-19 pandemic on STIs in Greece. Sex Transm Infect. 2022;98(1):70. doi:10.1136/sextrans-2021-054965
15. de Miguel Buckley R, Trigo E, de la Calle-Prieto F, Arsuaga M, Díaz-Menéndez M. Social distancing to combat COVID-19 led to a marked decrease in food-borne infections and sexually transmitted diseases in Spain. J Travel Med. 2020;27(8):taaa134. doi:10.1093/jtm/taaa134
16. Chia CC, Chao CM, Lai CC. Diagnoses of syphilis and HIV infection during the COVID-19 pandemic in Taiwan. Sex Transm Infect. 2021;97(4):319.
doi:10.1136/sextrans-2020-054802
17. World Health Organization. Disruption in HIV, Hepatitis and STI services due to COVID-19. 2020. Available from: https://www.who.int/docs/default-source/hiv-hq/presentation-disruption-in-services-international-aids-conference-2020.pdf?sfvrsn=d4bf1f87_7.
18. Jewell BL, Mudimu E, Stover J, et al. Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models. Lancet HIV. 2020;7(9):e629-e640.
doi:10.1016/S2352-3018(20)30211-3
19. Dorward J, Khubone T, Gate K, et al. The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis. Lancet HIV. 2021;8(3):e158-e165.
doi:10.1016/S2352-3018(20)30359-3
20. Walker D & Walker G. Still Neglected and Still Not Gone: The Implications of COVID-19 for the WHO Policy of Elimination of Congenital Syphilis. 2021. Available from: https://www.cgdev.org/blog/still-neglected-and-still-not-gone-implications-covid-19-who-policy-elimination-congenital
21. Napoleon SC, Maynard MA, Almonte A, et al. Considerations for STI Clinics During the COVID-19 Pandemic. Sex Transm Dis. 2020;47(7):431-3. doi:10.1097/OLQ.0000000000001192.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Satiti Retno Pudjiati, Nurwestu Rusetiyanti, Devi Artami Susetiati, Alessandro Alfieri
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
